DARPA to Explore Treatments to Multi-Drug Resistant Infections

DARPA to Explore Treatments to Multi-Drug Resistant Infections

The Defense Advanced Research Projects Agency (DARPA) has launched an effort to better protect warfighters from infectious microbes that are resistant to antibiotics. DARPA said Friday that its Harnessing Enzymatic Activity for Lifesaving Remedies or HEALR program seeks to design and deliver medical countermeasures to treat microbial infections that stem from multi-drug resistant organisms.

HEALR will leverage cellular science to further understand how to address and neutralize MDR microbes. The agency plans to post a broad agency announcement soon on the beta.SAM.gov website.

“HEALR presents the opportunity to identify drugs that are safer, more effective and better address drug resistance and bacterial infections than existing therapeutic modalities,” said Seth Cohen, who manages the HEALR program.

You may also be interested in...

Paul Olexa

USAF Airman Paul Olexa Pitches Idea to Reduce Foreign Debris Threats

Paul Olexa, a 1st class airman from the U.S. Air Force, used his past experience as a factory manager to create a floor mat designed to reduce foreign object debris that threatens aircraft safety. Olexa pitched his “Mag Rug” idea as an entry to the Spark Tank competition that took place in October at Whiteman Air Force Base.